To include your compound in the COVID-19 Resource Center, submit it here.

Versartis plummets on Phase III GHD miss

Versartis Inc. (NASDAQ:VSAR) lost $18.93 (88%) to $2.67 on Friday after

Read the full 113 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE